281 – 290 of 328
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
(
- Contribution to journal › Article
-
Mark
Solution structures of human and porcine beta-microseminoprotein
(
- Contribution to journal › Article
-
Mark
The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus
(
- Contribution to journal › Article
-
Mark
Hormone therapy: Improving therapy decisions and monitoring
(
- Contribution to journal › Article
-
Mark
CYSTATIN C AND NEUROENDOCRINE DIFFERENTIATION IN THE MALE REPRODUCTIVE SYSTEM AND IN PROSTATE CANCER
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
(
- Contribution to journal › Article
- 2005
-
Mark
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
(
- Contribution to journal › Article
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Localisation of Protein Kinase C in Apoptosis and Neurite Outgrowth
2005)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Prognostic value of serum markers for prostate cancer
(
- Contribution to journal › Article